Washington · statute · Wash. Rev. Code ch. 69.65 · 4 active provisions
(1) The legislature finds that the federal 340B drug pricing program is essential for providing health care access to low-income and uninsured populations. The 340B drug pricing program requires drug manufacturers to offer discounts on outpatient medications to eligible providers that serve these populations. They incl…
The definitions in this section apply throughout this chapter unless the context clearly requires otherwise.(1) "340B drug" means a drug that has been subject to an offer for reduced prices by a manufacturer under 42 U.S.C. Sec. 256b and is purchased by a covered entity.(2) "Covered entity" means an entity authorized t…
(1) A manufacturer or a third party acting on behalf of a manufacturer may not, directly or indirectly, deny, restrict, or prohibit the acquisition of a 340B drug by, or delivery of a 340B drug to, a covered entity, a pharmacy that is under contract with a covered entity to receive and dispense a 340B drug on behalf of…
(1) In addition to any other remedy provided by law, a covered entity may file a civil action against a manufacturer or a third party acting on behalf of a manufacturer for a violation of this chapter. If a court finds that the manufacturer or third party acting on behalf of a manufacturer violated this chapter, the co…